World Phage Week: Day 2: Phage Therapy Commercialization and Market Pathways — Dr. Mayukh Das October 29, 2025 The World Phage Week (October 22-28) 2025 is here, celebrating the birthday of Frederick Twort, a pioneer in phage research. This year, to mark…
World Phage Week: Day 1: Regulatory Framework on Phage Therapy — Dr. Tobi Nagel October 23, 2025 The World Phage Week (October 22-28) 2025 is here, celebrating the birthday of Frederick Twort, a pioneer in phage research. This year, to mark…
Audmula to Fight Against Phages October 15, 2025 We know that phages — viruses that kill bacteria —are beneficial to us, and active and robust studies are underway to develop them. However,…
Phagos Secures €25 Million to Advance AI-Driven Phage Therapy for Livestock October 10, 2025 Phagos, a French biotechnology company pioneering AI-powered phage therapy, has raised €25 million (US$29 million) in a Series A funding round to accelerate its…
AI-Designed Phage Genomes Show Promise Against Antibiotic Resistance September 21, 2025 Researchers from Arc Institute and collaborators have demonstrated that AI foundation models—Evo 1 and Evo 2—can design fully functional phage genomes, offering a new…
Guntur Doctor Successfully Use Phage Therapy to Cure Drug Resistant Bone Infection September 7, 2025 In a groundbreaking medical achievement, doctors from Guntur, Andhra Pradesh, India, have successfully treated a severe drug-resistant bone infection using phage therapy. The patient,…
MicrobiotiX extends its funding to first Korean phage clinical trial September 4, 2025 The Korean Ministry of Health and Welfare’s “Infectious Disease Prevention and Treatment Technology Development Project” has selected Microbiotix to conduct the first Korean phage…
Phage and AI come together to fight antimicrobial resistance at Phagos July 8, 2025 Recently, Amazon has published an article on Phagos. Phagos an AI tech-bio start-up company, has utilized Amazon Web Services(AWS) to develop an AI model….
Intralytix using Phages as Precision Medicine July 2, 2025 Moving away from the traditional “one-size-fits-all” approach to medicine, the precision medicine approach tailors treatment and prevention strategies to an individual’s unique characteristics, aiming…
CRISPR armed phage therapeautic to treat cancer patients June 26, 2025 SNIPR Biome has conducted a randomized, double-blinded, placebo-controlled clinical trial. This is a Phase 1b clinical trial of SNIPR001 in patients with hematological cancer….